Stock Information


VGW

$1.24 Today’s price
-0.06 24-hour Change ($)
-4.62% 24-hour Change (%)
185639 24-hour Volume

Market Summary

Press Releases

VALENS GROWORKS ANNOUNCES ISO 17025 ACCREDITATION - Kelowna, B.C., June 14, 2018 –Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multi-licensed vertically integrated provider of cannabis products and services utilizing proprietary extraction processes, is pleased…
Valens GroWorks Announces Additions to Management and Key Partnerships - KELOWNA, BC, June 7, 2018 /CNW/ – Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens“), a multi-licensed, vertically integrated provider of cannabis products and services with a focus on proprietary extraction processes is…
Valens GroWorks enters into cannabis supply, expansion, and services agreement with SpeakEasy - Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multi-licensed, vertically integrated provider of cannabis products, is pleased to announce a multi-purpose partnership agreement (the “Agreement”) with SpeakEasy Cannabis Club…

View All

This is Valens

Poised for Success

The medical and recreational cannabis markets are estimated to be worth a combined $23 billion annually.

Ready to Grow

Our cultivation facilities are operational and configured to expand pending our Licensed Producer approval. Phase one revenue is estimated in excess of $7M. Phase 2 construction is scheduled to begin after LP approval.

A Path to Revenue

Our industry-first approval allows the production of 100% cannabis oil for immediate sale through our supply agreement with Canopy Growth. That provides VGW with immediate revenue that stands to increase significantly with July’s pending recreational legalization.

Sales on the Rise

Medical Cannabis users in Canada are forecast to increase from 200,000 today to over 700,000 by 2020. The recreational market is expected to exceed $20B annually. Sales of cannabis oil have increased over 300% in the past year.

Medical Market Snapshot

700,000
Medical Patients Registered in Canada by 2020

180,000 KG
Estimated Annual Demand of Medical Grade Cannabis

$1.2B
Canadian Medical Market Size

The Valens Advantage

  • Mitacs research grants
  • Custom formulations
  • Good Manufacturing Practice
  • International markets

Recreational Market Snapshot

22%
Of Canadian adult population consumes recreational cannabis on an occasional basis

600,000 KG
Estimated annual demand for recreational cannabis

$22.6B
Potential market size

The Valens Advantage

  • Premium dried flower
  • Premium Oil and derivatives
  • Custom Manufacturing
  • Phase I buildout complete

Public Filings

SEDAR Financial News

Learn more

For more information, contact investor relations at scott@valensgroworks.com or 705-888-2756.